Heart Test Laboratories' Q1 Earnings Reveal GAAP EPS of -$2.64, Missing Estimates

Thursday, 12 September 2024, 20:50

Heart Test Laboratories GAAP EPS of -$2.64 misses by $0.18 in Q1 earnings release. The financial report highlights cash and cash equivalents of $4.3 million.
LivaRava_Finance_Default_1.png
Heart Test Laboratories' Q1 Earnings Reveal GAAP EPS of -$2.64, Missing Estimates

Heart Test Laboratories' Q1 Earnings Report

Heart Test Laboratories, trading under NASDAQ:HSCS, has reported a GAAP EPS of -$2.64 during the first quarter, which missed analysts' expectations by $0.18. This disappointing earnings figure reflects ongoing financial challenges within the company and raises questions about its future strategies.

Financial Highlights

  • Cash and Cash Equivalents: $4.3 million
  • Shareholder’s Equity: $5.9 million

Despite the missed EPS estimates, the report provides insight into the company’s liquidity situation.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe